The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 trial of cirmtuzumab and ibrutinib: Planned analysis of phase 1 CLL cohorts.
 
Michael Y. Choi
Consulting or Advisory Role - Abbvie/Genentech; Rigel
Speakers' Bureau - Abbvie; Genentech; Gilead Sciences; Pharmacyclics
Research Funding - Pharmacyclics (Inst)
 
William G. Wierda
Consulting or Advisory Role - Sanofi
Research Funding - Abbvie; Acerta Pharma; Cyclacel; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Loxo; miRagen; Oncternal Therapeutics, Inc; Pharmacyclics; Sunesis Pharmaceuticals; Xencor
 
Hun Ju Lee
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Seagen (Inst); Takeda (Inst)
 
Dimitrios Tzachanis
Consulting or Advisory Role - Jazz Pharmaceuticals
Speakers' Bureau - Takeda
 
Xen Ianopulos
Employment - Oncternal Therapeutics, Inc
 
Deborah Jezior
Employment - Oncternal Therapeutics, Inc
Stock and Other Ownership Interests - Oncternal Therapeutics, Inc
 
James Bradley Breitmeyer
Employment - Oncternal Therapeutics, Inc
Leadership - Oncternal Therapeutics, Inc; Otonomy; Zogenix
Stock and Other Ownership Interests - Bavarian Nordic; Oncternal Therapeutics, Inc; Oncternal Therapeutics, Inc (I); Otonomy; Zogenix
Patents, Royalties, Other Intellectual Property - Inventor on patent(s)
Travel, Accommodations, Expenses - Oncternal Therapeutics, Inc; Zogenix
 
Catriona HM Jamieson
Research Funding - Celgene (Inst); Johnson & Johnson (Inst)
Patents, Royalties, Other Intellectual Property - Forty Seven
 
Thomas J. Kipps
Employment - Moores Cancer Center
Honoraria - Pharmacyclics/ AbbVie/ Janssen/ Celgene/Genentech/ Roche/ Gilead/ Dava Oncology
Consulting or Advisory Role - AbbVie/ Pharmacyclics/ Celgene/ Genentech/ Roche/ Leukemia / Janssen/ Dava Oncology/ Gilead
Speakers' Bureau - Verastem/Pharmacyclics
Travel, Accommodations, Expenses - Travel/ Honoraria covered by the companies below